Hybio Pharmaceutical Co., Ltd. (SZSE:300199) agreed to acquire 10.81% stake in Hybio Biotechnology (Dali) Co., Ltd. from Dazhong Transportation (Group) Co., Ltd. (SHSE:600611) for CNY 20 million on May 10, 2022. After the repurchase is completed, Hybio Pharmaceutical will hold 69.22% of Hybio Biotechnology. As on December 31, 2021, Hybio Pharmaceutical reported total assets of approximately CNY 110 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.24 CNY | -3.09% | -4.97% | -9.87% |
1st Jan change | Capi. | |
---|---|---|
-9.87% | 1.54B | |
+21.09% | 43.27B | |
+25.28% | 22.92B | |
+19.22% | 15.43B | |
+13.51% | 12.95B | |
+44.01% | 11.83B | |
-7.79% | 6.91B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.02% | 5.55B |
- Stock Market
- Equities
- 300199 Stock
- News Hybio Pharmaceutical Co., Ltd.
- Hybio Pharmaceutical Co., Ltd. agreed to acquire 10.81% stake in Hybio Biotechnology Co., Ltd. from Dazhong Transportation Co., Ltd. for CNY 20 million.